184 related articles for article (PubMed ID: 1657506)
1. Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach.
Hawkey CJ; Hawthorne AB; Hudson N; Cole AT; Mahida YR; Daneshmend TK
Clin Sci (Lond); 1991 Oct; 81(4):565-73. PubMed ID: 1657506
[TBL] [Abstract][Full Text] [Related]
2. Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans.
Hudson N; Murray FE; Cole AT; Filipowicz B; Hawkey CJ
Gut; 1997 Jul; 41(1):19-23. PubMed ID: 9274466
[TBL] [Abstract][Full Text] [Related]
3. Review article: aspirin and gastrointestinal bleeding.
Hawkey CJ
Aliment Pharmacol Ther; 1994 Apr; 8(2):141-6. PubMed ID: 8038346
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.
Hawthorne AB; Mahida YR; Cole AT; Hawkey CJ
Br J Clin Pharmacol; 1991 Jul; 32(1):77-83. PubMed ID: 1888645
[TBL] [Abstract][Full Text] [Related]
5. Protection of human gastric mucosa against aspirin-enteric coating or dose reduction?
Cole AT; Hudson N; Liew LC; Murray FE; Hawkey CJ; Heptinstall S
Aliment Pharmacol Ther; 1999 Feb; 13(2):187-93. PubMed ID: 10102949
[TBL] [Abstract][Full Text] [Related]
6. Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin.
Cole AT; Brundell S; Hudson N; Hawthorne AB; Mahida YR; Hawkey CJ
Aliment Pharmacol Ther; 1992 Dec; 6(6):707-15. PubMed ID: 1486156
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and the stomach.
Graham DY; Smith JL
Ann Intern Med; 1986 Mar; 104(3):390-8. PubMed ID: 3511824
[TBL] [Abstract][Full Text] [Related]
8. NSAID-induced gastric mucosal damage.
Semble EL; Wu WC
Am Fam Physician; 1987 Jun; 35(6):101-8. PubMed ID: 3332745
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract.
Marshall JK; Rainsford KD; James C; Hunt RH
Aliment Pharmacol Ther; 2000 Nov; 14(11):1451-7. PubMed ID: 11069316
[TBL] [Abstract][Full Text] [Related]
10. Reduction in gastric mucosal hemorrhage and ulceration with chronic high-level dosing of enteric-coated aspirin granules two and four times a day.
Lanza FL; Rack MF; Wagner GS; Balm TK
Dig Dis Sci; 1985 Jun; 30(6):509-12. PubMed ID: 3873326
[TBL] [Abstract][Full Text] [Related]
11. Effect of prostaglandin E2 on gastric mucosal bleeding caused by aspirin.
Hunt JN; Franz DR
Dig Dis Sci; 1981 Apr; 26(4):301-5. PubMed ID: 6972294
[TBL] [Abstract][Full Text] [Related]
12. Predictors of gastroduodenal erosions in patients taking low-dose aspirin.
Hart J; Hawkey CJ; Lanas A; Naesdal J; Talley NJ; Thomson AB; Yeomans ND
Aliment Pharmacol Ther; 2010 Jan; 31(1):143-9. PubMed ID: 19709095
[TBL] [Abstract][Full Text] [Related]
13. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
Goldstein JL; Scheiman JM; Fort JG; Whellan DJ
J Cardiovasc Pharmacol; 2016 Aug; 68(2):121-6. PubMed ID: 27002280
[TBL] [Abstract][Full Text] [Related]
14. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans.
Cryer B; Feldman M
Gastroenterology; 1999 Jul; 117(1):17-25. PubMed ID: 10381905
[TBL] [Abstract][Full Text] [Related]
15. Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers.
Nishino M; Sugimoto M; Kodaira C; Yamade M; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
Dig Dis Sci; 2010 Jun; 55(6):1627-36. PubMed ID: 19672708
[TBL] [Abstract][Full Text] [Related]
16. A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production.
Laine L; Sloane R; Ferretti M; Cominelli F
Gastrointest Endosc; 1995 Nov; 42(5):428-33. PubMed ID: 8566633
[TBL] [Abstract][Full Text] [Related]
17. [Digestive and hemorrhage complications of low-dose aspirin].
Sibilia J; Ravaud P; Marck G
Presse Med; 2003 Nov; 32(37 Pt 2):S17-28. PubMed ID: 14763350
[TBL] [Abstract][Full Text] [Related]
18. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P
Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284
[TBL] [Abstract][Full Text] [Related]
19. Role of melatonin in mucosal gastroprotection against aspirin-induced gastric lesions in humans.
Konturek PC; Konturek SJ; Celinski K; Slomka M; Cichoz-Lach H; Bielanski W; Reiter RJ
J Pineal Res; 2010 May; 48(4):318-23. PubMed ID: 20443220
[TBL] [Abstract][Full Text] [Related]
20. Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth, and neutrophil activation.
Konturek JW; Dembinski A; Stoll R; Domschke W; Konturek SJ
Gut; 1994 Sep; 35(9):1197-204. PubMed ID: 7959223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
